|
1
|
Amado M, Almeida R, Schwientek T and
Clausen H: Identification and characterization of large
galactosyltransferase gene families: Galactosyltransferases for all
functions. Biochim Biophys Acta. 1473:35–53. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qasba PK, Ramakrishnan B and Boeggeman E:
Structure and function of beta -1,4-galactosyltransferase. Curr
Drug Targets. 9:292–309. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Appert HE, Rutherford TJ, Tarr GE, Wiest
JS, Thomford NR and McCorquodale DJ: Isolation of a cDNA coding for
human galactosyltransferase. Biochem Biophys Res Commun.
139:163–168. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hennet T: The galactosyltransferase
family. Cell Mol Life Sci. 59:1081–1095. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lopez LC, Youakim A, Evans SC and Shur BD:
Evidence for a molecular distinction between Golgi and cell surface
forms of beta 1,4-galactosyltransferase. J Biol Chem.
266:15984–15991. 1991.PubMed/NCBI
|
|
6
|
Choi HJ, Chung TW, Kim CH, Jeong HS, Joo
M, Youn B and Ha KT: Estrogen induced β-1,4-galactosyltransferase 1
expression regulates proliferation of human breast cancer MCF-7
cells. Biochem Biophys Res Commun. 426:620–625. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu W, Cui Z, Wang Y, Zhu X, Fan J, Bao G,
Qiu J and Xu D: Elevated expression of β1,4-galactosyltransferase-I
in cartilage and synovial tissue of patients with osteoarthritis.
Inflammation. 35:647–655. 2012. View Article : Google Scholar
|
|
8
|
Zhou H, Ma H, Wei W, Ji D, Song X, Sun J,
Zhang J and Jia L: B4GALT family mediates the multidrug resistance
of human leukemia cells by regulating the hedgehog pathway and the
expression of p-glycoprotein and multidrug resistance-associated
protein 1. Cell Death Dis. 4:e6542013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mengle-Gaw L, McCoy-Haman MF and Tiemeier
DC: Genomic structure and expression of human
beta-1,4-galactosyltransferase. Biochem Biophys Res Commun.
176:1269–1276. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shaper NL, Charron M, Lo NW and Shaper JH:
Beta1,4-galactosyltransferase and lactose biosynthesis: Recruitment
of a housekeeping gene from the nonmammalian vertebrate gene pool
for a mammary gland specific function. J Mammary Gland Biol
Neoplasia. 3:315–324. 1998. View Article : Google Scholar
|
|
11
|
Zhang S, Cai M, Zhang SW, Hu Y and Gu JX:
Involvement of beta 1,4 galactosyltransferase 1 and Gal
beta1-->4GlcNAc groups in human hepatocarcinoma cell apoptosis.
Mol Cell Biochem. 243:81–86. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu X, Jiang J, Shen H, Wang H, Zong H, Li
Z, Yang Y, Niu Z, Liu W, Chen X, et al: Elevated
beta1,4-galactosyltransferase I in highly metastatic human lung
cancer cells. Identification of E1AF as important transcription
activator. J Biol Chem. 280:12503–12516. 2005. View Article : Google Scholar
|
|
13
|
Poeta ML, Massi E, Parrella P, Pellegrini
P, De Robertis M, Copetti M, Rabitti C, Perrone G, Muda AO,
Molinari F, et al: Aberrant promoter methylation of beta-1,4
galactosyltransferase 1 as potential cancer-specific biomarker of
colorectal tumors. Genes Chromosomes Cancer. 51:1133–1143. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Radhakrishnan P, Chachadi V, Lin MF, Singh
R, Kannagi R and Cheng PW: TNF,α enhances the motility and
invasiveness of prostatic cancer cells by stimulating the
expression of selective glycosyl- and sulfotransferase genes
involved in the synthesis of selectin ligands. Biochem Biophys Res
Commun. 409:436–441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamashita H, Kubushiro K, Ma J, Fujii T,
Tsukazaki K, Iwamori M and Nozawa S: Alteration in the metastatic
potential of ovarian cancer cells by transfection of the antisense
gene of beta-1,4-galactosyltransferase. Oncol Rep. 10:1857–1862.
2003.PubMed/NCBI
|
|
16
|
Zhou H, Zhang Z, Liu C, Jin C, Zhang J,
Miao X and Jia L: B4GALT1 gene knockdown inhibits the hedgehog
pathway and reverses multidrug resistance in the human leukemia
K562/adriamycin-resistant cell line. IUBMB Life. 64:889–900. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang X, Monitto CL, Demokan S, Kim MS,
Chang SS, Zhong X, Califano JA and Sidransky D: Identification of
hyper-methylated genes associated with cisplatin resistance in
human cancers. Cancer Res. 70:2870–2879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Helleman J, Jansen MP, Span PN, van
Staveren IL, Massuger LF, Meijervan Gelder ME, Sweep FC, Ewing PC,
van der Burg ME, Stoter G, et al: Molecular profiling of platinum
resistant ovarian cancer. Int J Cancer. 118:1963–1971. 2006.
View Article : Google Scholar
|
|
19
|
Yuan Q, Yang H, Cheng C, Li C, Wu X, Huan
W, Sun H, Zhou Z, Wang Y, Zhao Y, et al:
β-1,4-Galactosyltransferase I involved in Schwann cells
proliferation and apoptosis induced by tumor necrosis factor-alpha
via the activation of MAP kinases signal pathways. Mol Cell
Biochem. 365:149–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim MS, Louwagie J, Carvalho B, Terhaar
Sive Droste JS, Park HL, Chae YK, Yamashita K, Liu J, Ostrow KL,
Ling S, et al: Promoter DNA methylation of oncostatin m
receptor-beta as a novel diagnostic and therapeutic marker in colon
cancer. PLoS One. 4:e65552009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Michailidi C, Soudry E, Brait M, Maldonado
L, Jaffe A, Ili-Gangas C, Brebi-Mieville P, Perez J, Kim MS, Zhong
X, et al: Genome-wide and gene-specific epigenomic platforms for
hepatocellular carcinoma biomarker development trials.
Gastroenterol Res Pract. 2014:5971642014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Forrest AR, Kawaji H, Rehli M, Baillie JK,
de Hoon MJ, Haberle V, Lassmann T, Kulakovskiy IV, Lizio M, Itoh M,
et al; FANTOM Consortium and the RIKEN PMI and CLST (DGT). A
promoter-level mammalian expression atlas. Nature. 507:462–470.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang C, Bolotin E, Jiang T, Sladek FM and
Martinez E: Prevalence of the initiator over the TATA box in human
and yeast genes and identification of DNA motifs enriched in human
TATA-less core promoters. Gene. 389:52–65. 2007. View Article : Google Scholar :
|
|
24
|
Hsu PC, Chao CC, Yang CY, Ye YL, Liu FC,
Chuang YJ and Lan CY: Diverse Hap43-independent functions of the
Candida albicans CCAAT-binding complex. Eukaryot Cell. 12:804–815.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ko LJ and Engel JD: DNA-binding
specificities of the GATA transcription factor family. Mol Cell
Biol. 13:4011–4022. 1993.PubMed/NCBI
|
|
26
|
Blauwkamp TA, Chang MV and Cadigan KM:
Novel TCF-binding sites specify transcriptional repression by Wnt
signalling. EMBO J. 27:1436–1446. 2008.PubMed/NCBI
|
|
27
|
Gardiner-Garden M and Frommer M: CpG
islands in vertebrate genomes. J Mol Biol. 196:261–282. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hackenberg M, Barturen G, Carpena P,
Luque-Escamilla PL, Previti C and Oliver JL: Prediction of
CpG-island function: CpG clustering vs. sliding-window methods. BMC
Genomics. 11:3272010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ornstein RL, Rein R, Breen D and Macelroy
R: An optimized potential function for the calculation of nucleic
acid interaction energies I. base stacking. Biopolymers.
17:2341–2360. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vesth T, Lagesen K, Acar Ö and Ussery D:
CMG-biotools, a free workbench for basic comparative microbial
genomics. PLoS One. 8:e601202013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ginno PA, Lott PL, Christensen HC, Korf I
and Chédin F: R-loop formation is a distinctive characteristic of
unmethylated human CpG island promoters. Mol Cell. 45:814–825.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Seila AC, Core LJ, Lis JT and Sharp PA:
Divergent transcription: A new feature of active promoters. Cell
Cycle. 8:2557–2564. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang MQ, Koehly LM and Elnitski LL:
Comprehensive annotation of bidirectional promoters identifies
co-regulation among breast and ovarian cancer genes. PLOS Comput
Biol. 3:e722007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Orekhova AS and Rubtsov PM: Bidirectional
promoters in the transcription of mammalian genomes. Biochemistry
(Mosc). 78:335–341. 2013. View Article : Google Scholar
|
|
35
|
Yang MQ and Elnitski LL: Diversity of core
promoter elements comprising human bidirectional promoters. BMC
Genomics. 9(Suppl 2): S32008.PubMed/NCBI
|
|
36
|
Zhang W, He L, Liu W, Sun C and Ratain MJ:
Exploring the relationship between polymorphic (TG/CA)n repeats in
intron 1 regions and gene expression. Hum Genomics. 3:236–245.
2009.PubMed/NCBI
|
|
37
|
De La Rosa-Velázquez IA, Rincón-Arano H,
Benítez-Bribiesca L and Recillas-Targa F: Epigenetic regulation of
the human retinoblastoma tumor suppressor gene promoter by CTCF.
Cancer Res. 67:2577–2585. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Carninci P, Kasukawa T, Katayama S, Gough
J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al;
RIKEN Genome Exploration Research Group and Genome Science Group
(Genome Network Project Core Group). The transcriptional landscape
of the mammalian genome. Science. 309:1559–1563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Uesaka M, Nishimura O, Go Y, Nakashima K,
Agata K and Imamura T: Bidirectional promoters are the major source
of gene activation-associated non-coding RNAs in mammals. BMC
Genomics. 15:352014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lepoivre C, Belhocine M, Bergon A, Griffon
A, Yammine M, Vanhille L, Zacarias-Cabeza J, Garibal MA, Koch F,
Maqbool MA, et al: Divergent transcription is associated with
promoters of transcriptional regulators. BMC Genomics. 14:9142013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Magistri M, Faghihi MA, St Laurent G III
and Wahlestedt C: Regulation of chromatin structure by long
noncoding RNAs: Focus on natural antisense transcripts. Trends
Genet. 28:389–396. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kung JT, Colognori D and Lee JT: Long
noncoding RNAs: Past, present, and future. Genetics. 193:651–669.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hamada H, Petrino MG and Kakunaga T: A
novel repeated element with Z-DNA-forming potential is widely found
in evolutionarily diverse eukaryotic genomes. Proc Natl Acad Sci
USA. 79:6465–6469. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hamada H, Seidman M, Howard BH and Gorman
CM: Enhanced gene expression by the poly(dT-dG).poly(dC-dA)
sequence. Mol Cell Biol. 4:2622–2630. 1984.PubMed/NCBI
|
|
45
|
Dutreix M: (GT)n repetitive tracts affect
several stages of RecA-promoted recombination. J Mol Biol.
273:105–113. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Huang W, Zheng J, He Y and Luo C: Tandem
repeat modification during double-strand break repair induced by an
engineered TAL effector nuclease in zebrafish genome. PLoS One.
8:e841762013. View Article : Google Scholar
|
|
47
|
Hui J, Hung L-H, Heiner M, Schreiner S,
Neumüller N, Reither G, Haas SA and Bindereif A: Intronic CA-repeat
and CA-rich elements: A new class of regulators of mammalian
alternative splicing. EMBO J. 24:1988–1998. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zenklusen JC, Bièche I, Lidereau R and
Conti CJ: (C-A)n micro-satellite repeat D7S522 is the most commonly
deleted region in human primary breast cancer. Proc Natl Acad Sci
USA. 91:12155–12158. 1994. View Article : Google Scholar
|
|
49
|
Mukherjee B, Zhao H, Parashar B, Sood BM,
Mahadevia PS, Klinger HP, Vikram B and Achary MP: Microsatellite
dinucleotide (T-G) repeat: A candidate DNA marker for breast
metastasis. Cancer Detect Prev. 27:19–23. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Frietze S, Wang R, Yao L, Tak YG, Ye Z,
Gaddis M, Witt H, Farnham PJ and Jin VX: Cell type-specific binding
patterns reveal that TCF7L2 can be tethered to the genome by
association with GATA3. Genome Biol. 13:R522012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hnisz D, Abraham BJ, Lee TI, Lau A,
Saint-André V, Sigova AA, Hoke HA and Young RA: Super-enhancers in
the control of cell identity and disease. Cell. 155:934–947. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pott S and Lieb JD: What are
super-enhancers? Nat Genet. 47:8–12. 2015. View Article : Google Scholar
|
|
53
|
Akiyama Y, Watkins N, Suzuki H, Jair KW,
van Engeland M, Esteller M, Sakai H, Ren CY, Yuasa Y, Herman JG, et
al: GATA-4 and GATA-5 transcription factor genes and potential
downstream antitumor target genes are epigenetically silenced in
colorectal and gastric cancer. Mol Cell Biol. 23:8429–8439. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zheng R and Blobel GA: GATA transcription
factors and cancer. Genes Cancer. 1:1178–1188. 2010. View Article : Google Scholar
|
|
55
|
Carpenter RL and Lo HW: Hedgehog pathway
and GLI1 isoforms in human cancer. Discov Med. 13:105–113.
2012.PubMed/NCBI
|
|
56
|
Arai MA, Uchida K, Sadhu SK, Ahmed F and
Ishibashi M: Physalin H from Solanum nigrum as an Hh signaling
inhibitor blocks GLI1-DNA-complex formation. Beilstein J Org Chem.
10:134–140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Faber K, Glatting KH, Mueller PJ, Risch A
and Hotz-Wagenblatt A: Genome-wide prediction of splice-modifying
SNPs in human genes using a new analysis pipeline called AASsites.
BMC Bioinformatics. 12(Suppl 4): S22011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Guo Y and Jamison DC: The distribution of
SNPs in human gene regulatory regions. BMC Genomics. 6:1402005.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kotani N, Asano M, Iwakura Y and Takasaki
S: Knockout of mouse beta 1,4-galactosyltransferase-1 gene results
in a dramatic shift of outer chain moieties of N-glycans from type
2 to type 1 chains in hepatic membrane and plasma glycoproteins.
Biochem J. 357:827–834. 2001. View Article : Google Scholar : PubMed/NCBI
|
